OPTIMIZING ROUTINE DELIVERY OF ESSENTIAL CHILD HEALTH AND NUTRITION PACKAGE THROUGH PRIMARY HEALTH CARE CONTACTS

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15+
SponsorNutrition International

About this trial

The primary objective of the study is to assess whether optimization of an essential package of health and nutrition services for children under five years of age using vitamin A supplementation touch points (i.e., the implementation model) in selected areas in Kenya and Senegal will increase the coverage of vitamin A supplementation and the coverage of other child health and nutrition services. In addition, the study will also assess the feasibility of the implementation model and the drivers of coverage outcomes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Caregivers of children 12-59 months of age

Health service providers

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Optimized package of child essential health and nutrition services

    Other intervention

    Optimized package of child essential health and nutrition services

  • Standard package of essential child and nutrition services

    Other intervention

    Standard package of essential child and nutrition services

Treatment groups

1,928 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 1 intervention
Group B: ControlOther 1 intervention

Trial outcomes

Primary outcomes

1

Children who received their age-appropriate VAS

The proportion of children 12-59 months of age who received their age-appropriate VAS

Time frame
From enrollment to the end of intervention at 12 months
2

Children who are immunized with measles vaccine

Proportion of children 12-23 months of age who are immunized with one dose of measles (MR1) in Kenya Proportion of children 24-35 months of age who are immunized with the second dose of measles (MR2) in Senegal

Time frame
From enrollment to the end of intervention at 12 months
3

Implementation feasibility of new model perceived by health service providers, as assessed by key informant interviews and focus groups

Feasibility of implementation of the new model as perceived by health service providers will be assessed via key informant interviews and focus groups to enquire on: i. Implementation barriers and facilitators ii. Practicality of implementing the optimization model within context and resource availability iii. Program disruption due to the implementation of the model iv. Need for infrastructure to implement the model v. Sustainability of the optimized model. All qualitative information will be triangulated to assess feasibility of implementation of the new model

Time frame
From enrollment to the end of intervention at 12 months
4

Fidelity of implementing the new model

Fidelity of implementation will be assessed by measuring: i. The proportion of health facilities preparing and using integrated microplans. ii. The proportion of supportive supervision visits carried out in an integrated way. iii. The proportion of service delivery points providing services in an integrated way Fidelity will be achieved if the three parameters score at least 80%.

Time frame
From enrollment to the end of intervention at 12 months

Secondary outcomes

1

Co-coverage of VAS and measles vaccine

Proportion of children 12-23 months of age who have received both their age-appropriate VAS and their age-appropriate vaccines (as measured by measles one) in Kenya Proportion of children 24-35 months of age who have received both their age-appropriate VAS and their age-appropriate vaccines (as measured by measles two) in Senegal

Time frame
From enrollment to the end of intervention at 12 months
2

Children screened for malnutrition in the last 6 months

The proportion of children 12-59 months of age who were screened for malnutrition in the last 6 months

Time frame
From enrollment to the end of intervention at 12 months
3

Children who have received growth monitoring service

The proportion of children 12-59 months who have received growth monitoring service

Time frame
From enrollment to the end of intervention at 12 months
4

Children who have received age-appropriate immunizations

The proportion of children 12-59 months who have received age-appropriate immunizations according to EPI schedule

Time frame
From enrollment to the end of intervention at 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Nutrition International

Lead sponsor

Kenya Ministry of Health

Collaborator

Cheikh Anta Diop University, Senegal

Collaborator

Senegal Ministry of Health

Collaborator

Henike Consultants

Collaborator